Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of “Moderate Buy” by Analysts

Option Care Health, Inc. (NASDAQ:OPCH) has been given an average rating of “Moderate Buy” by the fourteen brokerages that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation and eight have given a buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $30.0769.

Several research firms have weighed in on OPCH. Morgan Stanley set a $28.00 price objective on shares of Option Care Health in a research note on Wednesday, May 6th. Stephens reissued an “equal weight” rating and set a $24.00 target price (down from $30.00) on shares of Option Care Health in a research note on Friday, July 17th. Barrington Research lowered their price target on shares of Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a report on Friday, May 1st. Truist Financial set a $30.00 price target on shares of Option Care Health in a research note on Friday, May 1st. Finally, Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price objective for the company. in a report on Friday, May 1st.

Option Care Health Trading Up 3.1%

NASDAQ:OPCH opened at $22.48 on Wednesday. The stock has a market cap of $3.53 billion, a PE ratio of 17.43, a price-to-earnings-growth ratio of 1.21 and a beta of 0.65. Option Care Health has a fifty-two week low of $18.01 and a fifty-two week high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The stock’s 50-day moving average is $21.39 and its two-hundred day moving average is $26.94.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The firm’s revenue was up 1.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, equities research analysts forecast that Option Care Health will post 1.64 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of Option Care Health stock in a transaction dated Monday, May 4th. The stock was acquired at an average cost of $21.41 per share, for a total transaction of $783,820.10. Following the acquisition, the director directly owned 450,000 shares in the company, valued at $9,634,500. This represents a 8.86% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Timothy P. Sullivan purchased 24,154 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was purchased at an average cost of $20.69 per share, with a total value of $499,746.26. Following the purchase, the director owned 73,383 shares in the company, valued at $1,518,294.27. This represents a 49.06% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought a total of 73,264 shares of company stock valued at $1,548,316 in the last three months. Insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. V Square Quantitative Management LLC acquired a new stake in Option Care Health in the fourth quarter valued at approximately $25,000. Advisory Services Network LLC acquired a new position in shares of Option Care Health during the 3rd quarter worth $35,000. McIlrath & Eck LLC acquired a new position in shares of Option Care Health during the 2nd quarter worth $37,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Option Care Health during the 3rd quarter valued at $38,000. Finally, Quarry LP raised its holdings in shares of Option Care Health by 502.7% during the 3rd quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after purchasing an additional 1,292 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.